» Articles » PMID: 34009400

The Twilight Zone: Plasticity and Mixed Ontogeny of Neutrophil and Eosinophil Granulocyte Subsets

Overview
Publisher Springer
Date 2021 May 19
PMID 34009400
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

It is now becoming clear that neutrophils and eosinophils are heterogeneous cells with potentially multiple subsets in health and disease. With greater marker coverage by multi-color flow cytometry and single-cell level sequencing of granulocyte populations, novel phenotypes of these cells began to emerge. Intriguingly, many newly described subsets blend distinctions between classical myeloid lineage phenotypes, which are especially true for tissue resident or recruited cells in contexts of inflammation and disease. This includes reports of neutrophils with features of eosinophils, monocytes and dendritic cells, and eosinophil subsets expressing neutrophil markers. Moreover, novel studies show the ability of immature neutrophils to transdifferentiate into mature cells belonging to other myeloid lineages (eosinophils, monocytes/macrophages). In this review, we summarize novel findings in this exciting research frontier and shed light on potential processes driving the plasticity and heterogeneity of granulocyte subsets. Specifically, we discuss the hematopoietic flexibility of granulocyte precursors in bone marrow and the adaptation of myeloid cells to local tissue microenvironments. The understanding of such intermediate and developmental phenotypes is very important, as it can teach us about origins of functionally distinct myeloid cells during inflammation, and explain reasons for successes and failures of biologics targeting terminally differentiated granulocytes.

Citing Articles

The Association of Blood Eosinophils and Neutrophils Expressing Eosinophilic Surface Markers with the Severity and Outcome of COVID-19.

Wang J, Li X, Ren J, Rao Y, Qiao Y, Sun L Microorganisms. 2025; 12(12.

PMID: 39770705 PMC: 11727756. DOI: 10.3390/microorganisms12122503.


S100A9 induces tissue remodeling of human nasal epithelium in chronic rhinosinusitis with nasal polyp.

Ahn S, Oh J, Kim D, Lee E, Rha M, Cho H Int Forum Allergy Rhinol. 2024; 15(2):135-148.

PMID: 39367796 PMC: 11785152. DOI: 10.1002/alr.23460.


Not just for lymphoid cells: the role of the noncanonical NF-κB signaling pathway in early and late myelopoiesis with a focus on hypereosinophilic disorders.

Trusiano B, Zimmerman K, Morrison H, Allen I J Leukoc Biol. 2024; 116(2):297-306.

PMID: 38682253 PMC: 11288383. DOI: 10.1093/jleuko/qiae101.


Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.

Meng X, Zhang H, Dong L, Min Q, Yu M, Li Y Blood Adv. 2024; 8(7):1667-1682.

PMID: 38286463 PMC: 11006815. DOI: 10.1182/bloodadvances.2023012171.


Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia.

Chang L, Choi A, Rathnasinghe R, Warang P, Noureddine M, Jangra S Front Immunol. 2023; 14:1217181.

PMID: 37600776 PMC: 10437116. DOI: 10.3389/fimmu.2023.1217181.


References
1.
Giese M, Hind L, Huttenlocher A . Neutrophil plasticity in the tumor microenvironment. Blood. 2019; 133(20):2159-2167. PMC: 6524564. DOI: 10.1182/blood-2018-11-844548. View

2.
Hong C . Current Understanding in Neutrophil Differentiation and Heterogeneity. Immune Netw. 2017; 17(5):298-306. PMC: 5662779. DOI: 10.4110/in.2017.17.5.298. View

3.
Lee J, Jacobsen E, McGarry M, Schleimer R, Lee N . Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy. 2010; 40(4):563-75. PMC: 2951476. DOI: 10.1111/j.1365-2222.2010.03484.x. View

4.
Bugl S, Wirths S, Muller M, Radsak M, Kopp H . Current insights into neutrophil homeostasis. Ann N Y Acad Sci. 2012; 1266:171-8. DOI: 10.1111/j.1749-6632.2012.06607.x. View

5.
Abdala-Valencia H, Coden M, Chiarella S, Jacobsen E, Bochner B, Lee J . Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. J Leukoc Biol. 2018; 104(1):95-108. PMC: 6013365. DOI: 10.1002/JLB.1MR1117-442RR. View